A detailed history of Harris Associates L P transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Harris Associates L P holds 1,473,084 shares of CRL stock, worth $247 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,473,084
Previous 1,162,935 26.67%
Holding current value
$247 Million
Previous $176 Million 30.62%
% of portfolio
0.38%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$145.57 - $178.99 $45.1 Million - $55.5 Million
310,149 Added 26.67%
1,473,084 $230 Million
Q2 2025

Aug 14, 2025

BUY
$99.75 - $151.89 $116 Million - $177 Million
1,162,935 New
1,162,935 $176 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Harris Associates L P Portfolio

Follow Harris Associates L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harris Associates L P, based on Form 13F filings with the SEC.

News

Stay updated on Harris Associates L P with notifications on news.